Group items tagged

The US Food and Drug Administration (FDA) has now approved the use of Omalizumab, commercially known as Xolair, for the treatment of chronic hives

Fycompa (perampanel), the first in an entirely new class of treatment for partial onset seizures (the most common form of epilepsy), will be launched in the Netherlands on 13 May 2014.

Cobroxin is one such product that has gained lots of popularity in the past few years. the merchandise is comparatively new within the market. However, the kind of demand it's clearly shows that it's mighty effective. Over the years, several corporations and makers have come up with products that claim relief from joint and muscle pain. However, it appears that Cobroxin is actually one among the most effective pain relief products ever created.

Anadrol 50 is the highly potent anabolic steroid which appeared under the name of Androyd and Anadrol 50 in the 1960s. Also referred to as A50, the steroid brings about a significant weight gain. In US, it has become a very potent androgen used orally.

To be honest, I've never heard of this guy named Joel Marion before and what it is. I do not know if he was just a scam artist on the Internet or if your fat loss diet may Xtreme also known as diet extreme fat loss product that really was worth the money.

Lots of men and women are investing in this method which the Creators has labelled the "Quantity 1 Honest and All-natural Diet and Diet Program".

PBR Staff Writer Published 20 March 2014 Ireland-based specialty pharmaceutical firm Actavis has entered into an agreement with Noven Pharmaceuticals to settle all outstanding patent litigation related to its generic version of Daytrana (Methylphenidate Transdermal System). Daytrana is a CNS stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.

PBR Staff Writer Published 25 March 2014 US-based Goodwin Biotechnology has entered into an agreement with Aspyrian Therapeutics for the technology transfer, process development, scale-up, and cGMP manufacturing of a new Antibody Drug Conjugate (ADC) for use in Phase I clinical trials.

PBR Staff Writer Published 21 March 2014 Novartis has launched the Lucentis (ranibizumab) pre-filled syringe (PFS) in Germany and plans to introduce the product in other markets throughout 2014. In October 2013, the company has received approval from the European authorities for Lucentis PFS, which is a new way of administering Lucentis that is specifically designed for intraocular injection to enhance patient safety and convenience for the treating clinician.

The packaged food, drink and grocery product manufacturers in New South Wales, Australia, are set to launch a new program to increase the recycling of bottles and plastic drink containers in the state.

Before using any supplement, it is wise to know about their side-effects. Thankfully mass gainers do not have any serious side-effects.

There are several protein supplements for bodybuilding that we can avail in recent times, out of which Whey & Casein protein are very popular.

Eardoc - the best solution to treat an ear infection and relieve ear pain * Alternative for ear tube surgery * Immediate ear pain relief * Suitable for both children and adults.

The cancer journal is an important and reliable source of current information on developments in the field, cancer journal research updates is a peer reviewed journals.

The global anti-obesity Drugs Market is segmented in by product:-Peripherally acting anti-obesity agents, centrally acting anti-obesity drugs; by mode of action:-Fat Absorption Inhibition, Food Intake Suppression:- Noradrenergic Drugs, Serotoninergic Drugs, Adrenergic Drug, Others; Increase Thermogenesis; Segmentation by Type:- Prescription Drugs, Over the Counter Drugs; Segmentation by Distribution Channel:- Hospital Pharmacy, Retail Pharmacy and by regions. Anti-Obesity Drugs Market is anticipated to mask a significant CAGR during the forecast period i.e. 2015-2021. Anti-obesity drugs are pharmacological agents that are used to lose cholesterol and reduce the body weight. These drugs generally show their action by altering the fundamental functioning of the normal body by utilization of calories or by altering the appetite. The World Health Organization reveals that global obesity has more than doubled since 1980, with over 1.9 billion adults overweight in 2014, of which, more than 600 million were obese

Today,i found an interesting site,it's called the vinefire.com.It appears to be a social bookmarking site along with additional earning opportunity.Vinefire at present is in the beta phase,they have a plan to be acquired by a larger company,and they claim